This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Spinal Muscular Atrophy
Information about Spinal Muscular Atrophy: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Spinal Muscular Atrophy
Most recent studies have shown that Spinal Muscular Atrophy shares some biological mechanisms with amyotrophic-lateral-sclerosis, atrophy, charcot-marie-tooth-disease, dystrophy, hmn-(hereditary-motor-neuropathy)-proximal-type-i, motor-neuron-disease, muscle-weakness, muscular-atrophy, muscular-dystrophy, myopathy, nerve-degeneration, neurodegenerative-disorders, neuromuscular-diseases, primary-lateral-sclerosis, sclerosis, spinal-and-bulbar-muscular-atrophy-x-linked-1, spinal-cord-diseases, spinal-muscular-atrophies-of-childhood, weakness.
Among the many pathways, these few ones have gauged particular interests from scientists studying Spinal Muscular Atrophy, and have been seen in publications frequently: Cell Death, Gene Conversion, Innervation, Localization, Locomotion, Methylation, Muscle Atrophy, Myelination, Neurogenesis, Neuron Death, Neuroprotection, Pathogenesis, Programmed Cell Death, Reflex, Regeneration, Rna Interference, Rna Processing, Rna Splicing, Translation, Transport
Quite a number of genes have been found to play important roles in Spinal Muscular Atrophy, such as AKR1B1, AR, AREG, COIL, DDX20, DMD, FDXR, GEMIN2, IGFALS, IGHMBP2, NAIP, SMN1, SNRPN, SOD1, STMN1, ZEB2. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.